Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension
Cardiology in the Young · 2024
DOI: 10.1017/s1047951124000362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Gamze Vuran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, University of Health Sciences, İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital,…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Leukotriene B4, Heart Defects, Congenital, Pulmonary Artery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
The aim of this study is to evaluate the role of leukotriene B4, an inflammatory mediator, in the development of pulmonary hypertension in paediatric patients with CHD with left-right shunt.
Methods
The study included forty patients with CHD with left-right shunts. Based on haemodynamic data obtained from cardiac diagnostic catheterisation, 25 patients who met the criteria for pulmonary arterial hypertension were included in the patient group. The control group comprised 15 patients who did not meet the criteria. The standard cardiac haemodynamic study was conducted. Leukotriene B4 levels were assessed in blood samples taken from both pulmonary arteries and peripheral veins.
Results
The median age of patients with pulmonary arterial hypertension was 10 months (range: 3–168), while the median age of the control group was 50 months (range: 3–194). In the pulmonary hypertension group, the median pulmonary artery systolic/diastolic/mean pressures were 38/18/24 mmHg, compared to 26/10/18 mmHg in the control group. Leukotriene B4 levels in pulmonary artery blood samples were significantly higher in the pulmonary arterial hypertension group compared to the controls (p < 0.05). Peripheral leukotriene B4 levels were also elevated in the pulmonary arterial hypertension group in comparison to the control group, though the difference was not statistically significant.
Conclusion
The discovery of elevated leukotriene B4 levels in pulmonary artery samples from paediatric patients with pulmonary arterial hypertension secondary to CHD with left-to-right shunt suggests that local inflammation may have a pathological role in the development of pulmonary arterial hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, University of Health Sciences, İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir, Turkey.
ORCID-Profile: Gamze Vuran, Murat Muhtar Yılmazer, Engin Gerçeker, Cüneyt Zihni, Timur Meşe
Zitieren
APA
Vuran, G., Yılmazer, M. M., Gerçeker, E., Zihni, C., & Meşe, T. (2024). Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension. Cardiology in the Young. https://doi.org/10.1017/s1047951124000362
Vancouver
Vuran G, Yılmazer MM, Gerçeker E, Zihni C, Meşe T. Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension. Cardiology in the Young. 2024. doi:10.1017/s1047951124000362
BibTeX
@article{Vuran2024,
author = {Vuran, Gamze and Yılmazer, Murat Muhtar and Gerçeker, Engin and Zihni, Cüneyt and Meşe, Timur},
title = {Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension},
journal = {Cardiology in the Young},
year = {2024},
doi = {10.1017/s1047951124000362}
}
EUVIMED